Suppr超能文献

雾化吸入可溶性一氧化氮供体可改善急性肺损伤患者的氧合及肺动脉高压。

Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury.

作者信息

Jacobs B R, Brilli R J, Ballard E T, Passerini D J, Smith D J

机构信息

Division of Critical Care Medicine and Department of Pathology, Children's Hospital Medical Center, Cincinnati, Ohio, USA.

出版信息

Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1536-42. doi: 10.1164/ajrccm.158.5.9802114.

Abstract

Acute respiratory distress syndrome (ARDS) is a major cause of morbidity and mortality in critically ill patients. The associated ventilation/perfusion mismatch and pulmonary hypertension are amenable to treatment with inhaled nitric oxide (NO) gas. Compounds formed by reacting NO with various nucleophiles (NONOates) release NO spontaneously and induce vasodilation. Intratracheally administered NONOates result in selective reduction in pulmonary hypertension. We hypothesized that a nebulized NONOate would improve oxygenation and reduce pulmonary vascular resistance in oleic acid-induced acute lung injury and pulmonary hypertension. Pigs underwent catheterization of the pulmonary artery, left atrium, and right atrium, and a flow probe was positioned around the pulmonary artery. Acute lung injury and pulmonary hypertension were induced with intravenous oleic acid. Animals were randomly assigned to receive either nebulized saline or the NONOate 2-(dimethylamino)ethylputreanine/NO (DMAEP/NO). Hemodynamic, gas exchange, pulmonary function, methemoglobin, and nitrite/nitrate measurements were obtained for 60 min. Animals in the DMAEP/NO group had improvement in PaO2 as compared with control animals (from 139 +/- 19 mm Hg to 180 +/- 19 mm Hg in the DMAEP/NO group [n = 6]; and from 144 +/- 6 mm Hg to 150 +/- 9 mm Hg in the saline group [n = 6], p < 0.05). After aerosol treatment, animals in the DMAEP/NO group had a greater reduction in pulmonary vascular resistance index (PVRI) than did control animals (from 81 +/- 17 dyne. s/cm5/kg to 34 +/- 8 dyne. s/cm5/kg; and from 104 +/- 16 dyne. s/cm5/kg to 64 +/- 11 dyne. sec/cm5/ kg in the saline group at 60 min, p < 0.05). There were no differences between the groups in systemic vascular resistance index (SVRI), cardiac index (CI), methemoglobin, nitrite/nitrate, or lung pathology scores. We conclude that DMAEP/NO improves oxygenation and has selective pulmonary vasodilating properties without causing significant systemic toxicity in this porcine model of acute lung injury.

摘要

急性呼吸窘迫综合征(ARDS)是危重症患者发病和死亡的主要原因。相关的通气/灌注不匹配和肺动脉高压可通过吸入一氧化氮(NO)气体进行治疗。NO与各种亲核试剂反应形成的化合物(NONOates)会自发释放NO并诱导血管舒张。气管内给予NONOates可使肺动脉压选择性降低。我们推测雾化吸入NONOate可改善油酸诱导的急性肺损伤和肺动脉高压患者的氧合并降低肺血管阻力。对猪进行肺动脉、左心房和右心房插管,并在肺动脉周围放置流量探头。静脉注射油酸诱导急性肺损伤和肺动脉高压。动物被随机分配接受雾化生理盐水或NONOate 2-(二甲氨基)乙基腐胺/NO(DMAEP/NO)。在60分钟内进行血流动力学、气体交换、肺功能、高铁血红蛋白以及亚硝酸盐/硝酸盐测量。与对照组动物相比,DMAEP/NO组动物的动脉血氧分压(PaO2)有所改善(DMAEP/NO组从139±19 mmHg升至180±19 mmHg [n = 6];生理盐水组从144±6 mmHg升至150±9 mmHg [n = 6],p < 0.05)。雾化治疗后,DMAEP/NO组动物的肺血管阻力指数(PVRI)比对照组动物降低得更多(从81±17达因·秒/厘米5/千克降至34±8达因·秒/厘米5/千克;生理盐水组在60分钟时从104±16达因·秒/厘米5/千克降至64±11达因·秒/厘米5/千克,p < 0.05)。两组在体循环血管阻力指数(SVRI)、心脏指数(CI)、高铁血红蛋白、亚硝酸盐/硝酸盐或肺病理评分方面无差异。我们得出结论,在这种急性肺损伤猪模型中,DMAEP/NO可改善氧合并具有选择性肺血管舒张特性,且不会引起明显的全身毒性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验